Retatrutide

Price range: $1,199.00 through $2,499.00

16 mg/mL

48 mg, 8-10 weeks - 1199
64 mg, 10-13 weeks - 1599
96 mg, 14-16 weeks - 2099
128 mg, 17- 20 weeks - $2499

*The mg amount reflects total medication per vial. Estimated weeks are based on typical starting doses and may decrease as your dosage increases. Duration varies by individual response and titration. Contact us anytime with questions.

EARLY METABOLIC RESET ON RETATRUTIDE (IMPORTANT)

Ready to experience the next generation in weight loss? Retatrutide works on three key hormones simultaneously, delivering faster, deeper, and longer-lasting results.

Key Benefits

  • Significant Weight Loss – Helps accelerate fat reduction and supports long-term results
  • Craving Control – Powerful appetite suppression makes sticking to your plan easier
  • Enhanced Metabolism – Glucagon activation promotes fat burning and higher energy output
  • Blood Sugar Support – Improves glucose regulation and insulin sensitivity
  • Liver & Heart Health – Shown to reduce liver fat and improve cardiometabolic markers

Pay Later With Cherry

expected Weight Loss Over Time

8 weeks: 10-15 lbs.

10 - 12 weeks: 15-20 lbs.

13 - 15 weeks: 25-30 lbs.

16 - 20 weeks: 35+ lbs.

Expected weight-loss ranges are estimates based on typical clinical outcomes. Individual results vary and depend on factors including dosing/titration schedule, starting weight, metabolism, adherence, medical history, and lifestyle. Best results occur with a balanced diet, adequate protein intake, hydration, and consistent exercise. No results are guaranteed.

Learn how to administer safely in seconds.

Intramuscular Injections
Subcutaneous Injections

Additional information

Quantity

$1,199 – 8 Weeks (48 mg), $1,599 – 10-12 Weeks (64 mg), $2,099 – 13-15 Weeks (96 mg), $2,499 – 16-20 Weeks (128 mg)

Retatrutide is the next evolution in healthy weight management

Retatrutide is the newest breakthrough in weight management, working through three powerful metabolic pathways at once:

GLP-1 (Glucagon-Like Peptide-1): Suppresses appetite, slows gastric emptying, and improves blood sugar control.
GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances the effect of GLP-1, further reducing cravings and stabilizing glucose levels.
Glucagon: Stimulates fat metabolism and increases energy expenditure, helping the body burn fat more efficiently.

This triple-action approach makes Retatrutide one of the most advanced and effective options available for long-term weight management.

What to Expect When Starting Retatrutide Treatment

Many patients coming off Semaglutide or Tirzepatide are in a depleted state — low muscle glycogen, disrupted insulin sensitivity, slowed gastric emptying, and overall suppressed metabolic flexibility.

Retatrutide corrects this quickly.

During the first 2–6 weeks, the following can occur:

Glycogen Repletion: Retatrutide normalizes insulin sensitivity, causing muscle cells to pull glucose back in. Each gram of glycogen binds 3–4 grams of water, leading to temporary water weight.

Cellular Water Redistribution: Multi-pathway activation (GLP-1 + GIP + glucagon) produces short-term fluid shifts and mild subcutaneous fullness

Hormonal Adjustment: Changes in leptin, estrogen sensitivity, and sodium handling can cause temporary bloating or breast fullness.

This is not fat gain.

This is a normal metabolic correction phase after long periods on GLP-1 therapy.

Fat loss typically becomes more visible around weeks 6–10 as water normalizes and metabolic rate stabilizes.